Commercial Launch Of Sustained Release Intraocular Implant For Improved Glaucoma Treatment Outcomes Is Playing A Role In Shaping The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Progress Between 2026 And 2030?
The minimally invasive glaucoma surgery (migs) devices market size has experienced significant expansion in recent years. Projections indicate it will grow from $0.89 billion in 2025 to $1.14 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 28.1%. This historical development is attributable to factors such as the increasing prevalence of glaucoma, a growing aging population, the limitations of conventional glaucoma surgeries, heightened awareness of vision preservation, and the increasing adoption of cataract surgeries.
The minimally invasive glaucoma surgery (migs) devices market size is projected to experience significant expansion in the coming years. It is anticipated to reach $2.79 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 24.9%. This growth throughout the forecast period can be primarily attributed to an expanding population of glaucoma patients, increasing acceptance of minimally invasive surgical options, a rising demand for outpatient ophthalmic procedures, a greater focus on quality-of-life outcomes, and improved access to specialized ophthalmology clinics. Furthermore, major trends in the forecast period involve the increasing adoption of minimally invasive glaucoma procedures, a growing preference for MIGS in early and moderate glaucoma, the escalating use of MIGS combined with cataract surgery, an expansion of outpatient and ambulatory glaucoma surgeries, and an increasing demand for safer and quicker-recovery glaucoma treatments.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Factors Are Influencing The Growth Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The escalating incidence of eye disorders is anticipated to fuel the growth of minimally invasive glaucoma surgery (MIGS) devices moving forward. Eye disorders encompass a diverse array of conditions that influence both ocular health and vision. This increase in eye disorder prevalence stems from shifts in lifestyle, environmental influences, and the growing elderly population. Minimally invasive glaucoma surgery (MIGS) devices are innovative instruments employed in addressing various ophthalmic diseases, with a core focus on reducing intraocular pressure (IOP) to prevent or control the advancement of glaucoma. As an illustration, the National Eye Institute, a US government organization, stated in 2024 that around 2.2 million Americans are expected to be blind or partially blind by 2030. Thus, the rising occurrence of eye disorders acts as a key driver for the minimally invasive glaucoma surgery (MIGS) devices market.
How Is The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Categorized Across Its Segment Groups?
The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –
1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices
2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures
3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space
4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals
Subsegments:
1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents
2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts
3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents
4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices
Which Trends Are Influencing Demand In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Leading companies in the minimally invasive glaucoma surgery (MIGS) devices market are prioritizing the development of sophisticated solutions, such as sustained-release drug-delivery implants, to substitute traditional topical glaucoma treatments. A sustained-release implant is defined as a device designed to dispense medication continuously over a period, thereby improving patient commitment to treatment, decreasing dosing frequency, and enhancing overall therapeutic efficacy. An illustrative example occurred in February 2024, when Celanese Corporation, a US-based specialty materials firm, partnered with Glaukos for the commercial introduction of the iDose® TR (Travoprost Intracameral Implant). This product employs Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This breakthrough innovation offers continuous intraocular delivery of travoprost directly into the eye for several months, replacing conventional eye-drop routines. Integrated within Glaukos’ MIGS portfolio, it presents a minimally invasive treatment option that reduces the daily requirement for eye drops, enhances patient adherence, and supports sustained control of intraocular pressure, ultimately leading to improved long-term treatment outcomes.
Which Firms Are Influencing Competition In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International
Get The Full Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:
Which Region Accounts For The Largest Portion Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2026, By The Business Research Company
Glaucoma Surgery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report
Cataract Surgery Devices And Equipment Market Report 2026
Ophthalmic Handheld Surgical Instruments Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
